EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis

The Clinical Respiratory Journal
Martina DoubkováMartina Vašáková

Abstract

Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. Therefore, we decided to analyze the factors influencing IPF prognosis based on the real-practice data from our IPF registry. Data of 514 subjects consecutively entered since 2012 into Czech EMPIRE IPF registry were analyzed. Median age of our patient cohort was 67 years (50-82). Median overall survival (OS) of the cohort was 63.1 months. The clinical course of IPF according to FVC (forced vital capacity) changes was stabilized in 32.8% of patients (29.7% according to DLCO [diffuse lung capacity] changes), slowly progressive in 39.5% (45%), rapidly progressive in 23.5% (20.7%); and 1.7% patients had at least one acute exacerbation during follow-up. Deterioration in FVC of ≥10% at month 12 and in DLCO of ≥15% at months 12, 18, and 24 influenced the OS significantly. The fast progressors defined by the DLCO decline rate had higher risk of death compared to those defined by the FVC change over time. In multivariate analysis, age ≥70 years, interstitial HRCT scores ≥3, and change in DLCO...Continue Reading

References

Jan 1, 1994·Acta Universitatis Palackianae Olomucensis Facultatis Medicae·V Kolek
Jan 1, 1997·American Journal of Respiratory and Critical Care Medicine·K B BaumgartnerJ A Waldron
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·S E GayF J Martinez
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·T E KingR M Cherniack
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·T E KingR M Cherniack
Mar 29, 2003·American Journal of Respiratory and Critical Care Medicine·Athol U WellsDavid M Hansell
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Harold R CollardKevin K Brown
Jan 11, 2005·American Journal of Respiratory and Critical Care Medicine·Yangjin JegalThomas V Colby
May 17, 2005·American Journal of Respiratory and Critical Care Medicine·David A LynchUNKNOWN Idiopathic Pulmonary Fibrosis Study Group
Jun 22, 2005·Annals of Internal Medicine·Fernando J MartinezUNKNOWN IPF Study Group
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Sep 2, 2005·The European Respiratory Journal·J WangerG Viegi
Oct 6, 2005·The European Respiratory Journal·V CottinUNKNOWN Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P)
Oct 6, 2005·The European Respiratory Journal·N MacintyreJ Wanger
Jun 2, 2006·Proceedings of the American Thoracic Society·Dong Soon KimTalmadge E King
Jul 1, 2006·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuGerry Oster
Jul 11, 2006·American Journal of Respiratory and Critical Care Medicine·Kevin R FlahertyFernando J Martinez
Jun 23, 2007·American Journal of Respiratory and Critical Care Medicine·Harold R CollardUNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators
Nov 3, 2007·American Journal of Respiratory and Critical Care Medicine·Hiromitsu SumikawaNestor L Müller
Jun 16, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kazuyoshi KurashimaYutaka Sugita
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Brett LeyTalmadge E King
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
May 17, 2011·Lancet·Paul W NobleUNKNOWN CAPACITY Study Group
May 28, 2011·American Journal of Respiratory and Critical Care Medicine·Roland M du BoisTalmadge E King
Jan 14, 2012·The European Respiratory Journal·Marco MuraPaola Rogliani
May 16, 2012·Annals of Internal Medicine·Brett LeyHarold R Collard
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group
Sep 10, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Keishi SuginoSakae Homma

❮ Previous
Next ❯

Citations

Mar 8, 2018·Respiration; International Review of Thoracic Diseases·Demosthenes BourosUNKNOWN INDULGE IPF Study Group
Jul 10, 2019·The Annals of Pharmacotherapy·Roy Pleasants, Robert M Tighe
Jul 7, 2020·BMJ Open Respiratory Research·Laurie D SnyderTimothy Pm Whelan
Sep 8, 2019·Respiratory Research·Toby M Maher, Mary E Strek
Mar 16, 2019·Respiratory Research·Martin Kolb, Martina Vašáková
Jul 16, 2019·ERJ Open Research·Jaana KaunistoMarjukka Myllärniemi
Dec 13, 2019·Multidisciplinary Respiratory Medicine·Caitlin QuinnStephenie T Manns
May 31, 2019·Respiratory Research·Laurie SnyderUNKNOWN IPF-PRO™ Registry investigators
Apr 30, 2019·American Journal of Respiratory and Critical Care Medicine·Daniel A CulverHyun J Kim
Jun 19, 2019·Respiratory Research·Estrella Fernández-FabrellasUNKNOWN SEPAR-IPF National Registry
Jan 10, 2020·BMC Pulmonary Medicine·Luca RicheldiGanesh Raghu
Nov 27, 2020·Respiratory Research·Stéphane JouneauVincent Cottin
Aug 11, 2020·Annals of the American Thoracic Society·Bonnie R WangKevin R Flaherty
Jun 18, 2021·The Nurse Practitioner·Tyonn BarberaNina M Patel
Jan 10, 2021·The European Respiratory Journal·Imre NothUNKNOWN INMARK trial investigators
Sep 4, 2021·Therapeutic Advances in Respiratory Disease·Anoop M NambiarJeffrey A Sparks
Sep 14, 2021·Therapeutic Advances in Respiratory Disease·Martina DoubkovaMartina Vasakova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.